PR3 and thrombin are key modulators of IL-8 in the preterm lung – targeting of processing of IL-8 provides an attractive therapeutic target to prevent pulmonary inflammation in infants at risk of developing BPD. This evidence concerns the gene CXCL8 and bronchopulmonary dysplasia.